Company Overview

Company name: PharmaCann
Description: Operator of a vertically integrated cannabis company intended to provide safe, reliable and quality cannabis products to improve people’s lives. The company specializes in cultivating, processing, dispensing medicinal cannabis products and developing new forms and formulations of cannabinoid-based treatments for adult and pediatric patients, thereby providing users with effective, affordable and trusted cannabis products and services that help them live better lives.
Year founded: 2014
Parent company:
Industry: Healthcare | Group: | Code:
Website: www.pharmacann.com
Employees: 600
City: Chicago
State: Illinois
Country: United States
Region:

Financial Highlights

Start up capital raised (USD Million): 110.38
Business status: Generating Revenue
Ownership: Privately Held (backing)
Exchange:
Ticker:
Revenue (USD Million): 75.00
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period: FY 2019
Financing Status: The company raised $19.62 million of venture funding from undisclosed investors on May 11, 2020. Previously, the company reached a definitive agreement to be acquired by MedMen (CNQ: MMEN) for $682 million on February 8, 2019. Subsequently, the deal was canceled.
Number of active investors:
Profile last updated: 22-May-2020
Last known valuation:
Last known valuation date: 08-Feb-2019